Mark Kupersmith, MD Email Mark Kupersmith
- PROFESSOR | Neurology
- PROFESSOR | Neurosurgery
- PROFESSOR | Ophthalmology
- Hospital Affiliations
- Mount Sinai St. Luke's and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Beth Israel
- New York Eye and Ear Infirmary of Mount Sinai
- NYEE - East 102nd Street 212-636-3200 212-636-3200
Click here to read Dr. Kupersmith's CV.
AAO Honor Award
North American Neuro-Ophthalmology Society Distinguished Service Award 2009
Hoyt Lecture AAO 2014
Neurology, American Board of Psychiatry and Neurology
- Arteriovenous Malformation of the Brain
- Bell's Palsy
- Cavernous Malformations
- Myasthenia Gravis
- Neuromyelitis Optica
- Optic Neuritis
- Pituitary Adenoma
- Pituitary Tumor
- Temporal Arteritis
MRI, Neuroscience, Vision
MD, Northwestern University Medical School
NYU Medical Center
NYU Medical Center
English, SpanishDownload the CV
I have serve as Chair of the planning committee for NORDIC and directed NORDIC (February 2009-present), fulfilling all of the obligations outlined in NORDIC policies and in the Idiopathic Intracranial Hypertension Treatment Trial, the LIIHTT and for proposed studies, HIS and SiihTT. I intend to continue in the same capacity now as Director of the Enrollment and Resource Centers, administratively integrating studies, sites, investigators, reading centers, Data Coordinating and Biostatistical Center, managing sites and committees and overseeing finance, and scientifically contributing to the multi-site studies conducted across the US and Canada by NORDIC (Neuro-Ophthalmology Research Disease Investigator Consortium).
I direct an ECRIP center award at NYEEI, title 'Noninvasive optical imaging detection of changes in the peripapillary retina and optic nerve head due to damage of the optic nerve' which is currently studying glaucoma, optic neuritis, NAION, giant cell arteritis, and NMO. Each project is headed by a 'fellow' who are all subspecialty trained ophthalmologists or neurologists.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Kupersmith did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.